Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Phase 2a Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression

NCT05660642 is registered in ClinicalTrials.gov with Beckley Psytech Limited as lead sponsor.

NCT NCT05660642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05660642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Phase 2a Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression
Lead sponsor
Beckley Psytech Limited
Phase
Phase 2
Overall status
Recruiting
Start date
February 10, 2023
Completion date
November 30, 2026
Enrollment
72 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

treatment resistant depression